# PMV Pharmaceuticals, Inc.: filings

PMVP · Nasdaq · CIK 1699382 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pmvp.md) · [Financials](/companies/pmvp/financials.md) · [Filings](/companies/pmvp/filings.md) · [Insiders](/companies/pmvp/insiders.md)

## Reports and events: 84 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 160, 8-K 46, 3 27, SC 13G/A 26, 10-Q 18, SC 13G 14, SCHEDULE 13G/A 12, S-8 7, 10-K 6, CORRESP 6, DEF 14A 6, DEFA14A 6, SCHEDULE 13G 5, ARS 4, UPLOAD 4, 144 3, EFFECT 3, 424B3 2, 424B5 2, 4/A 2, S-1/A 2, SC 13D/A 2, SCHEDULE 13D/A 2, 3/A 1, 424B4 1, 8-A12B 1, CERT 1, D 1, DRS 1, DRS/A 1, DRSLTR 1, POS AM 1, POSASR 1, S-1 1, S-3 1, S-3ASR 1, SC 13D 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-05 | 13:00 ET | [8-K](/filings/0001193125-26-413254.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-413254 |
| 2026-09-02 | 22:23 ET | [8-K](/filings/0001193125-26-378838.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-378838 |
| 2026-08-31 | 20:06 ET | [8-K](/filings/0001193125-26-376723.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-376723 |
| 2026-08-14 | 12:00 ET | [10-Q](/filings/0001193125-26-350448.md) | Quarterly report, period 2026-06-30 | 0001193125-26-350448 |
| 2026-08-14 | 12:00 ET | [8-K](/filings/0001193125-26-350445.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-350445 |
| 2026-06-05 | 12:10 ET | [8-K](/filings/0001193125-26-258466.md) | 5.07 Shareholder vote results | 0001193125-26-258466 |
| 2026-05-12 | 12:00 ET | [10-Q](/filings/0001193125-26-218227.md) | Quarterly report, period 2026-03-31 | 0001193125-26-218227 |
| 2026-05-12 | 12:00 ET | [8-K](/filings/0001193125-26-218225.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-218225 |
| 2026-04-22 | 12:01 ET | [DEF 14A](/filings/0001140361-26-016038.md) | Proxy statement, period 2026-06-04 | 0001140361-26-016038 |
| 2026-03-06 | 13:24 ET | [8-K](/filings/0001193125-26-095094.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-095094 |
| 2026-03-06 | 13:01 ET | [10-K](/filings/0001193125-26-095014.md) | Annual report, period 2025-12-31 | 0001193125-26-095014 |
| 2026-03-04 | 02:12 ET | [SCHEDULE 13D/A](/filings/0000947871-26-000231.md) | Ownership report, active investor, amended | 0000947871-26-000231 |
| 2025-11-12 | 13:00 ET | [10-Q](/filings/0001193125-25-276003.md) | Quarterly report, period 2025-09-30 | 0001193125-25-276003 |
| 2025-11-12 | 13:00 ET | [8-K](/filings/0001193125-25-276000.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-276000 |
| 2025-10-27 | 21:12 ET | [SCHEDULE 13D/A](/filings/0000947871-25-000926.md) | Ownership report, active investor, amended | 0000947871-25-000926 |
| 2025-09-10 | 16:04 ET | [8-K](/filings/0001193125-25-199857.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-199857 |
| 2025-08-07 | 12:00 ET | [10-Q](/filings/0000950170-25-104588.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104588 |
| 2025-08-07 | 12:00 ET | [8-K](/filings/0000950170-25-104587.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104587 |
| 2025-06-09 | 13:02 ET | [8-K](/filings/0001193125-25-137497.md) | 5.07 Shareholder vote results | 0001193125-25-137497 |
| 2025-05-09 | 12:00 ET | [10-Q](/filings/0000950170-25-067513.md) | Quarterly report, period 2025-03-31 | 0000950170-25-067513 |
| 2025-05-09 | 12:00 ET | [8-K](/filings/0000950170-25-067511.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-067511 |
| 2025-04-25 | 13:00 ET | [DEF 14A](/filings/0001140361-25-015610.md) | Proxy statement, period 2025-06-05 | 0001140361-25-015610 |
| 2025-03-03 | 13:45 ET | [10-K](/filings/0000950170-25-030414.md) | Annual report, period 2024-12-31 | 0000950170-25-030414 |
| 2025-03-03 | 13:00 ET | [8-K](/filings/0000950170-25-030407.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-030407 |
| 2024-11-07 | 13:00 ET | [10-Q](/filings/0000950170-24-122817.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122817 |
| 2024-11-07 | 13:00 ET | [8-K](/filings/0000950170-24-122816.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122816 |
| 2024-08-08 | 12:00 ET | [10-Q](/filings/0000950170-24-093343.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093343 |
| 2024-08-08 | 12:00 ET | [8-K](/filings/0000950170-24-093345.md) | 1.02 Termination of a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093345 |
| 2024-06-07 | 12:32 ET | [8-K](/filings/0001193125-24-156745.md) | 5.07 Shareholder vote results | 0001193125-24-156745 |
| 2024-05-09 | 12:00 ET | [10-Q](/filings/0000950170-24-056295.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056295 |
| 2024-05-09 | 12:00 ET | [8-K](/filings/0000950170-24-056294.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056294 |
| 2024-04-24 | 12:00 ET | [DEF 14A](/filings/0001140361-24-021596.md) | Proxy statement, period 2024-06-06 | 0001140361-24-021596 |
| 2024-02-29 | 21:05 ET | [10-K](/filings/0000950170-24-023062.md) | Annual report, period 2023-12-31 | 0000950170-24-023062 |
| 2024-02-29 | 21:05 ET | [8-K](/filings/0000950170-24-023058.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-023058 |
| 2024-01-18 | 21:02 ET | [8-K](/filings/0001193125-24-010177.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-010177 |
| 2024-01-05 | 21:01 ET | [8-K](/filings/0001193125-24-003348.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-003348 |
| 2023-11-09 | 13:00 ET | [10-Q](/filings/0000950170-23-061551.md) | Quarterly report, period 2023-09-30 | 0000950170-23-061551 |
| 2023-11-09 | 13:00 ET | [8-K](/filings/0000950170-23-061552.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-061552 |
| 2023-10-12 | 21:02 ET | [8-K](/filings/0001193125-23-255083.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-255083 |
| 2023-10-11 | 20:02 ET | [8-K](/filings/0001193125-23-254135.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-254135 |
| 2023-08-23 | 20:56 ET | [SC 13D/A](/filings/0000947871-23-000902.md) | Ownership report, active investor, amended | 0000947871-23-000902 |
| 2023-08-09 | 12:01 ET | [10-Q](/filings/0000950170-23-040153.md) | Quarterly report, period 2023-06-30 | 0000950170-23-040153 |
| 2023-08-09 | 12:00 ET | [8-K](/filings/0000950170-23-040151.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-040151 |
| 2023-06-09 | 12:01 ET | [8-K](/filings/0001193125-23-164011.md) | 5.07 Shareholder vote results | 0001193125-23-164011 |
| 2023-05-10 | 12:02 ET | [10-Q](/filings/0000950170-23-020100.md) | Quarterly report, period 2023-03-31 | 0000950170-23-020100 |
| 2023-05-10 | 12:00 ET | [8-K](/filings/0000950170-23-020097.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-020097 |
| 2023-04-28 | 12:01 ET | [8-K](/filings/0001193125-23-124381.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-23-124381 |
| 2023-04-28 | 12:01 ET | [DEF 14A](/filings/0001140361-23-021220.md) | Proxy statement, period 2023-06-08 | 0001140361-23-021220 |
| 2023-03-01 | 13:02 ET | [10-K](/filings/0000950170-23-005345.md) | Annual report, period 2022-12-31 | 0000950170-23-005345 |
| 2023-03-01 | 13:01 ET | [8-K](/filings/0000950170-23-005343.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-005343 |

Page 1 of 2. [Older](/companies/pmvp/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.